<

BIOPHYTIS (EPA:ALBPS) - Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris

Transparency directive : regulatory news

01/07/2024 07:00

source : webdisclosure.com



Other stories

18/10/2024 04:10
17/10/2024 20:17
18/10/2024 01:27
17/10/2024 23:42
17/10/2024 19:08
17/10/2024 23:19
17/10/2024 17:08
17/10/2024 20:19
17/10/2024 19:37
17/10/2024 00:05
17/10/2024 15:02
17/10/2024 22:17
17/10/2024 16:45
17/10/2024 18:54
17/10/2024 23:00
17/10/2024 23:42
17/10/2024 19:08
17/10/2024 18:10
17/10/2024 19:40
17/10/2024 20:06
17/10/2024 08:00
17/10/2024 19:56
18/10/2024 03:31
18/10/2024 00:24
18/10/2024 04:00
17/10/2024 19:45
17/10/2024 22:26
17/10/2024 14:02
17/10/2024 13:59
16/10/2024 12:57
17/10/2024 21:56
17/10/2024 23:21
17/10/2024 07:41
16/10/2024 17:11